B cell-based therapies in CNS autoimmunity: differentiating CD19 and CD20 as therapeutic targets

B cell-based therapies in CNS autoimmunity: differentiating CD19 and CD20 as therapeutic targets

Increasing recognition of the role of B cells in the adaptive immune response makes B cells an important therapeutic target in autoimmunity. Numerous current and developmental immunotherapies target B cells for elimination through recognition of cell-surface proteins expressed specifically on B cell...

Full description

Bibliographic Details
Main Authors: Thomas G. Forsthuber, Daniel M. Cimbora, John Nolan Ratchford, Eliezer Katz, Olaf Stüve
Format: Article
Language:English
Published: SAGE Publishing 2018-03-01
Series:Therapeutic Advances in Neurological Disorders
Online Access:https://doi.org/10.1177/1756286418761697

Similar Items

Similar Items